Compare ERIC & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERIC | NTRA |
|---|---|---|
| Founded | 1876 | 2003 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.9B | 45.3B |
| IPO Year | 2002 | 2015 |
| Metric | ERIC | NTRA |
|---|---|---|
| Price | $10.03 | $338.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 15 |
| Target Price | $11.00 | ★ $259.07 |
| AVG Volume (30 Days) | ★ 9.0M | 1.4M |
| Earning Date | 04-17-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.82% | N/A |
| EPS Growth | N/A | ★ 0.65 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $210,939,000.00 |
| Revenue This Year | N/A | $18.08 |
| Revenue Next Year | $1.83 | $19.65 |
| P/E Ratio | $12.13 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.71 | $157.43 |
| 52 Week High | $13.77 | $337.12 |
| Indicator | ERIC | NTRA |
|---|---|---|
| Relative Strength Index (RSI) | 48.52 | 72.33 |
| Support Level | $9.26 | $187.64 |
| Resistance Level | $10.35 | N/A |
| Average True Range (ATR) | 0.13 | 10.88 |
| MACD | 0.06 | 1.95 |
| Stochastic Oscillator | 47.62 | 100.00 |
Ericsson is a networking equipment and software provider, primarily selling mobile networking equipment and services to wireless service providers. Ericsson operates in three segments: networks, cloud software and services, and enterprise. While large wireless carriers are its largest customers, Ericsson has expanded its offerings for large enterprises. These products and services include private 5G networking, contact centers as a service, and application performance interfaces. Ericsson aims to combine its 5G network expertise with cloud-native, as-a-service platforms offering a more comprehensive hardware and software package. Ericsson also monetizes its research and development investments by licensing patents to handset manufacturers.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.